LIVE WEBINAR

Eyes on GLP-1: Impact on Ocular Health

     

OVERVIEW

ADA Member Exclusive Webinar—Join American Diabetes Association® (ADA) professional members for Eyes on GLP‑1: Impact on Ocular Health, a focused, one‑hour live discussion exploring how GLP‑1 receptor agonists may influence ocular health. This session will review current evidence linking GLP‑1 therapy to various ocular outcomes and outline key monitoring and counseling considerations for patients using these therapies, concluding with practical insights and an interactive Q&A.

 

Hosted by the Eye Health Interest Group Leadership Team

LEARNING OBJECTIVES

  • Describe how GLP-1 receptor agonists may affect ocular health.
  • Review evidence linking GLP-1 therapy to ocular outcomes.
  • Identify monitoring and counseling considerations for patients on GLP-1 therapy.

DATE & TIME

Mar 25, 2026 12:00 PM - 1:00 PM ET

SPEAKER

Brian VanderBeek, MD, MPH, MSCE
Associate Professor of Ophthalmology at the Hospital of the University of Pennsylvania

MODERATOR

Andrew J. Barkmeier, M.D.
Ophthalmologist, Mayo Clinic

Android App Download IOS App Download Powered By